Exchange: NASDAQ·Updated 12:16 PM EDT
LGND logo

LGNDLigand Pharmaceuticals, Inc. - Ordinary Shares - Class B

$312.16
$10.46
(3.24%)
Today
EarningsAug 6
Mkt Cap$6.47B
Vol47,352.00
Upcoming Earnings: Q2 '26

Reports: Aug 06Pre-Market

Estimated EPS

$1.94

Estimated Rev

$62.32M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
$1.94
--
--
N/A
Q1 '26
$1.82
$1.63
-10.23%
MISSED
Q4 '25
$1.50
$2.02
34.92%
BEAT
Q3 '25
$1.93
$3.09
60.24%
BEAT
Q2 '25
$1.42
$1.60
12.56%
BEAT

Advertisement|Remove ads.